As the number of new drugs increases, physicians must choose the right obesity treatment for each patient, individualising the balance of benefits and adverse effects, say the authors of a linked Editorial To view or add a comment, sign in The needle era of obesity medicine may be ending
I can tell when it wears off because I start getting cravings again
Sharpe A, Morley L, Tang T, Norman R, Balen A
Discrete shipping to your door with ongoing support
In order to meet this moment marked by the rise of GLP-1s, we know what that looks like
FDA-approved treatments, like Wegovy and Ozempic, undergo rigorous clinical trials to ensure consistent quality, safety, and proven effectiveness for weight loss